bf/NASDAQ:LPTX_icon.jpeg

NASDAQ:LPTX

Leap Therapeutics, Inc.

  • Stock

USD

Last Close

0.41

06/11 22:17

Market Cap

75.00M

Beta: 0.74

Volume Today

217.02K

Avg: 600.93K

PE Ratio

−1.13

PFCF: −1.85

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
1.50M
-
1.50M
0%
cost of revenue
427K
-
gross profit
1.50M
-
1.50M
0%
-427K
-
selling and marketing expenses
-427K
-
general and administrative expenses
4.71M
-
5.72M
21.42%
4.23M
26.07%
9.85M
132.89%
8.92M
9.42%
9.09M
1.84%
9.62M
5.84%
10.77M
11.96%
11.80M
9.59%
13.81M
17.03%
12.85M
6.96%
selling general and administrative expenses
4.71M
-
5.72M
21.42%
4.23M
26.07%
9.85M
132.89%
8.92M
9.42%
9.09M
1.84%
9.62M
5.84%
10.77M
11.96%
11.80M
9.59%
13.38M
13.41%
12.85M
3.99%
research and development expenses
15.54M
-
15.37M
1.11%
23.29M
51.55%
22.50M
3.39%
21.07M
6.35%
24.37M
15.62%
20.42M
16.18%
32.16M
57.47%
44.97M
39.82%
73.23M
62.87%
57.21M
21.88%
other expenses
3.12M
-
756K
-
-132K
117.46%
-231K
75%
-1.23M
430.74%
-2.05M
67.29%
cost and expenses
20.25M
-
21.09M
4.13%
27.52M
30.50%
32.35M
17.55%
30.00M
7.29%
33.32M
11.08%
29.81M
10.54%
41.70M
39.90%
54.71M
31.20%
87.04M
59.09%
operating expenses
20.25M
-
21.09M
4.13%
27.52M
30.50%
32.35M
17.55%
30.00M
7.29%
33.32M
11.08%
29.81M
10.54%
41.70M
39.90%
54.71M
31.20%
86.61M
58.31%
70.06M
19.12%
interest expense
4.37M
-
18K
99.59%
1.23M
6,750%
121K
90.19%
19K
84.30%
23K
21.05%
39K
69.57%
41K
5.13%
54K
31.71%
ebitda
-19.73M
-
-20.46M
3.70%
-24.37M
19.14%
-32.18M
32.03%
-29.55M
8.18%
-33.01M
11.70%
-28.21M
14.52%
-40.19M
42.45%
-53.79M
33.83%
-86.61M
61.03%
-66.97M
22.69%
operating income
-20.92M
-
-21.09M
0.83%
-27.52M
30.50%
-32.35M
17.55%
-30.75M
4.95%
-33.45M
8.78%
-28.54M
14.68%
-41.43M
45.16%
-56.76M
37.02%
-87.04M
53.34%
-70.06M
19.51%
depreciation and amortization
657K
-
474K
27.85%
25K
94.73%
48K
92%
49K
2.08%
445K
808.16%
324K
27.19%
1.24M
281.17%
2.98M
140.97%
427K
85.65%
5K
98.83%
total other income expenses net
-663K
-
138K
120.81%
3.12M
2,160.87%
2.42M
22.47%
6.45M
166.60%
548K
91.50%
1.02M
86.68%
815K
20.33%
2.31M
183.93%
5.63M
143.17%
3.09M
45.14%
income before tax
-25.42M
-
-20.95M
17.58%
-25.63M
22.34%
-29.88M
16.59%
-23.12M
22.64%
-32.90M
42.33%
-27.52M
16.37%
-40.61M
47.59%
-54.45M
34.07%
-81.41M
49.52%
-66.97M
17.74%
income tax expense
31K
-
152K
390.32%
4.35M
2,763.82%
-157K
103.61%
20K
112.74%
-3K
115.00%
-2K
33.33%
-24K
1,100%
147K
712.50%
585K
-
net income
-25.45M
-
-21.10M
17.08%
-25.63M
21.46%
-29.73M
15.98%
-23.14M
22.17%
-32.90M
42.19%
-27.51M
16.37%
-40.59M
47.51%
-54.60M
34.52%
-81.41M
49.12%
-67.56M
17.02%
weighted average shs out
1.19M
-
1.71M
43.79%
939.24K
44.94%
916.18K
2.45%
1.41M
54.38%
2.26M
59.66%
5.93M
162.71%
8.58M
44.66%
113.24M
1,219.41%
20.45M
81.95%
37.55M
83.67%
weighted average shs out dil
1.19M
-
1.71M
43.79%
939.24K
44.94%
918.86K
2.17%
1.44M
56.85%
2.26M
56.69%
5.93M
162.71%
8.58M
44.66%
113.24M
1,219.41%
20.45M
81.95%
37.55M
83.67%
eps
-21.45
-
-12.37
42.33%
-27.29
120.61%
-32.45
18.91%
-16.36
49.58%
-14.57
10.94%
-4.64
68.15%
-4.73
1.94%
-0.48
89.85%
-3.98
729.17%
-1.81
54.52%
epsdiluted
-21.45
-
-12.37
42.33%
-27.29
120.61%
-32.35
18.54%
-16.05
50.39%
-14.57
9.22%
-4.64
68.15%
-4.73
1.94%
-0.48
89.85%
-3.98
729.17%
-1.81
54.52%

All numbers in USD (except ratios and percentages)